ASCENTAGE-B (06855) completes the placement of 22 million shares, raising approximately HK$1.4925 billion net proceeds, with old shares sold before new shares.

ASCENTAGE-B (06855) announced that all the conditions precedent for the placement have been fulfilled, and the placement was completed on July 17, 2025. The placement agent successfully placed a total of 22 million shares at a price of HK$68.60 per share to not less than six placees in accordance with the terms and conditions of the placement and subscription agreement. As all the conditions precedent for the subscription have also been fulfilled, the company issued and allotted 22 million subscription shares at a price of HK$68.60 per share (equivalent to the placement price) to the vendor on July 25, 2025, raising net proceeds of approximately HK$1.4925 billion. The funds raised will be used for commercialization activities, expanding coverage and enhancing patients' access to medical care; global clinical development to advance the company's core pipeline products; infrastructure and operational funds to strengthen global operations.